×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Medical Marijuana Market Analysis

ID: MRFR/Pharma/5008-CR
200 Pages
Rahul Gotadki
April 2025

Medical Marijuana Market Research Report By Application (Chronic Pain, Neurological Disorders, Cancer, Mental Health Disorders, Appetite Loss), By Formulation (Cannabinoid Oils, Dried Flowers, Edibles, Tinctures, Topicals), By Distribution Channel (Pharmacies, Online Stores, Dispensaries, Hospitals), By End Use (Medical Institutions, Homecare Settings, Research Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Marijuana Market Infographic
Purchase Options

Market Analysis

In-depth Analysis of Medical Marijuana Market Industry Landscape

The Medical Marijuana market is determined and shaped by a sophisticated mix of dimensional factors that mutually affect its functioning. One precipitating element that is pushing this market forward is the growing adoption and stipulation for medical marijuana as a remedy for health problems. As the curve of public perception bends in favor of endorsing the medicinal use of marijuana, a stream of consumers are willing to pay for medical cannabis as part of the expansion of the market.

The presence of medical breakthroughs in research and the marital with the evolving regulations results in the making of the medical marijuana market One of the missions of the continuing research efforts is to investigate the advantages of different cannabinoids that are there in marijuana and how they can be used for treating many health problems. As the regulatory landscape becomes more dynamic, the situation with the spread of medical marijuana in more regions modulating market access, competition and the growth outlook.

Economic factors are important influencers in the wellness cannabis market. Economic growth and stability usually lead to new investment into the medical cannabis sector, which then stimulates research, development and access to this natural remedy. In contrast, the pause of economy may result in the increased accessibility and affordability of medical marijuana hence the shifting of the market and consumer behavior.

Similarly, the strategic rivalry among cannabis producers and distributors is another important market factor. Competition will become more intense in the medical marijuana sector, especially from newcomers into the market, which will pave the way for increased innovation and development of different cannabis-based products. Strategic alliances, merges and acquisitions are important in the industry today as companies look to consolidate the market space and expand their product portfolio in such a way as to offer a favourable choice for patients.

Consumers’ taste buds and new trends in medicine also play a very important role for the medical marijuana industry. With patient demand for alternative and natural solutions, along with a rising trend towards holistic therapies, the medical marijuana industry is developing products based on these preferences and implementing marketing strategies. Organizations are adapting business models by developing a range of products formulations including oils, tinctures, edibles, as others and implementing new consumption methods to satisfy medical users.

Furthermore, the structure of the whole healthcare market and the existing medical laws influence the growth. The restriction of medical marijuana through medical practitioners’ approvals and regulatory conditions of availability determine both patient accessibility and market dictate. Reimbursement policies for medical marijuana and insurance coverage, payment issues also have a bearing on accessibility and customer choices.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

What is the current valuation of the Medical Marijuana Market?

The Medical Marijuana Market was valued at 18.34 USD Billion in 2024.

What is the projected market size for the Medical Marijuana Market by 2035?

The market is projected to reach 44.99 USD Billion by 2035.

What is the expected CAGR for the Medical Marijuana Market during the forecast period?

The expected CAGR for the Medical Marijuana Market from 2025 to 2035 is 8.5%.

Which companies are considered key players in the Medical Marijuana Market?

Key players include Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, Aphria, Canopy Growth, Aurora Cannabis, MedMen, and Harvest Health & Recreation.

What are the primary applications driving the Medical Marijuana Market?

Chronic pain, neurological disorders, cancer, mental health disorders, and appetite loss are the primary applications.

How much revenue is generated from the Chronic Pain segment in the Medical Marijuana Market?

The Chronic Pain segment generated 6.0 USD Billion in 2024 and is projected to reach 14.5 USD Billion by 2035.

What formulation types are prevalent in the Medical Marijuana Market?

Cannabinoid oils, dried flowers, edibles, tinctures, and topicals are prevalent formulation types.

What is the revenue projection for the Dried Flowers segment by 2035?

The Dried Flowers segment is projected to generate 12.0 USD Billion by 2035.

Which distribution channels are most significant in the Medical Marijuana Market?

Dispensaries, pharmacies, online stores, and hospitals are significant distribution channels.

What is the expected revenue from Medical Institutions by 2035?

Revenue from Medical Institutions is expected to reach 15.0 USD Billion by 2035.

Market Summary

As per MRFR analysis, the Medical Marijuana Market was estimated at 18.34 USD Billion in 2024. The Medical Marijuana industry is projected to grow from 19.9 USD Billion in 2025 to 44.99 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 8.5 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Medical Marijuana Market is experiencing robust growth driven by evolving regulations and increasing consumer acceptance.

  • North America remains the largest market for medical marijuana, characterized by a progressive regulatory landscape. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising demand for alternative therapies. Chronic pain management continues to dominate the market, while neurological disorders represent the fastest-growing segment. Key drivers include increasing acceptance of medical marijuana and advancements in research and development, enhancing product availability.

Market Size & Forecast

2024 Market Size 18.34 (USD Billion)
2035 Market Size 44.99 (USD Billion)
CAGR (2025 - 2035) 8.5%
Largest Regional Market Share in 2024 North America

Major Players

<p>Curaleaf (US), Trulieve (US), Green Thumb Industries (US), Cresco Labs (US), Aphria (CA), Canopy Growth (CA), Aurora Cannabis (CA), MedMen (US), Harvest Health &amp; Recreation (US)</p>

Market Trends

The Medical Marijuana Market is currently experiencing a transformative phase characterized by evolving regulations and increasing acceptance among healthcare professionals and patients alike. This shift appears to be driven by a growing body of research supporting the therapeutic benefits of cannabis, which may lead to broader applications in pain management, mental health, and chronic illness treatment. As more jurisdictions legalize medical marijuana, the market is likely to expand, attracting a diverse range of stakeholders, including pharmaceutical companies, healthcare providers, and investors. Furthermore, the integration of technology in cultivation and distribution processes seems to enhance efficiency and product quality, potentially reshaping consumer experiences and expectations. In addition, the Medical Marijuana Market is witnessing a surge in product innovation, with companies developing various formulations and delivery methods to cater to specific patient needs. This trend indicates a shift towards personalized medicine, where treatments are tailored to individual conditions and preferences. As public awareness increases and stigma diminishes, the market may continue to grow, fostering a more informed consumer base that seeks reliable and effective medical solutions. Overall, the Medical Marijuana Market appears poised for significant growth, driven by regulatory changes, technological advancements, and evolving consumer attitudes.

Regulatory Evolution

The landscape of the Medical Marijuana Market is undergoing substantial changes as governments worldwide reassess their policies regarding cannabis. This evolution suggests a trend towards more favorable regulations, which may facilitate easier access for patients and healthcare providers. As legal frameworks become more accommodating, the market could see an influx of new entrants and innovations.

Technological Integration

Advancements in technology are playing a crucial role in the Medical Marijuana Market, particularly in cultivation and distribution. Innovations such as precision agriculture and blockchain for supply chain transparency may enhance product quality and safety. This integration indicates a potential shift towards more efficient operations and improved consumer trust.

Product Diversification

The Medical Marijuana Market is experiencing a notable trend in product diversification, with companies developing a wide array of formulations and delivery methods. This trend reflects a growing understanding of patient needs and preferences, suggesting that personalized approaches to treatment may become increasingly prevalent.

Medical Marijuana Market Market Drivers

Expansion of Distribution Channels

The expansion of distribution channels is a critical factor influencing the Medical Marijuana Market. As regulations evolve, more dispensaries and online platforms are emerging, providing patients with easier access to medical marijuana products. This proliferation of distribution options not only enhances convenience but also fosters competition among suppliers, potentially leading to better pricing and product variety. Recent data suggests that the number of licensed dispensaries has increased by over 30% in the last two years, indicating a robust growth trajectory. This trend is likely to continue, further solidifying the Medical Marijuana Market's position in the healthcare landscape.

Advancements in Research and Development

Ongoing advancements in research and development within the Medical Marijuana Market are driving innovation and product efficacy. Scientific exploration into the pharmacological properties of cannabinoids has led to the development of more targeted therapies, enhancing the appeal of medical marijuana as a viable treatment option. For instance, research indicates that specific strains can effectively manage conditions such as epilepsy and multiple sclerosis. The investment in R&D is expected to increase, with projections suggesting that the market could reach a valuation of over 50 billion dollars by 2028. This focus on scientific validation is likely to bolster consumer confidence and expand the Medical Marijuana Market.

Growing Demand for Alternative Therapies

The increasing demand for alternative therapies is significantly impacting the Medical Marijuana Market. Patients are increasingly seeking non-pharmaceutical options for managing chronic pain, anxiety, and other health conditions, often turning to medical marijuana as a natural alternative. This shift is particularly evident among populations wary of traditional medications and their side effects. Market analysis indicates that the demand for medical marijuana products has surged, with sales projected to grow at a compound annual growth rate of over 20% in the coming years. This trend underscores the potential for the Medical Marijuana Market to cater to a diverse range of patient needs.

Increasing Acceptance of Medical Marijuana

The growing acceptance of medical marijuana among healthcare professionals and patients appears to be a pivotal driver in the Medical Marijuana Market. As more studies emerge highlighting the therapeutic benefits of cannabis, including pain relief and anti-inflammatory properties, healthcare providers are increasingly recommending it as a treatment option. This shift in perception is reflected in the rising number of states and countries legalizing medical marijuana, with over 40 jurisdictions having enacted laws to allow its use for various medical conditions. Consequently, the Medical Marijuana Market is likely to experience substantial growth as acceptance continues to expand, fostering a more favorable environment for both patients and producers.

Regulatory Support and Legalization Trends

Regulatory support and ongoing legalization trends are fundamental drivers of the Medical Marijuana Market. As governments recognize the potential health benefits and economic opportunities associated with medical marijuana, many are enacting supportive legislation. This includes not only the legalization of medical use but also the establishment of regulatory frameworks that ensure product safety and quality. Recent legislative changes in several regions have led to a marked increase in the number of licensed producers and dispensaries, contributing to market growth. The Medical Marijuana Market is likely to benefit from this regulatory momentum, paving the way for further expansion and innovation.

Market Segment Insights

By Application: Chronic Pain (Largest) vs. Neurological Disorders (Fastest-Growing)

<p>In the medical marijuana market, chronic pain applications command the largest share, accounting for a significant portion of the total market. Patients suffering from chronic conditions often turn to marijuana as a therapeutic option, leading to substantial demand in this area. In contrast, neurological disorders represent the fastest-growing segment, as awareness of the therapeutic benefits for conditions like epilepsy and multiple sclerosis rises, drawing both patients and healthcare providers toward cannabis-based treatments.</p>

<p>Chronic Pain (Dominant) vs. Neurological Disorders (Emerging)</p>

<p>Chronic pain remains the dominant application for medical marijuana, catering to a wide demographic with varying pain management needs. As healthcare systems increasingly acknowledge the limitations of traditional pain medications, patients are turning towards cannabis as a viable alternative, enhancing its market presence. On the other hand, neurological disorders are emerging with rapid growth potential. The expanding body of clinical research and anecdotal evidence supporting cannabis's efficacy in treating conditions like seizures and migraines is fueling this segment’s popularity, positioning it as a key area for innovation and investment in the medical marijuana market.</p>

By Formulation: Cannabinoid Oils (Largest) vs. Edibles (Fastest-Growing)

<p>In the medical marijuana market, Cannabinoid Oils continue to command the largest share, primarily due to their versatility and efficacy in treating various conditions. As patients seek alternative therapies for pain management, anxiety, and more, these oils have become a preferred choice among consumers. Dried Flowers follow closely but lack the concentrated benefits that oils offer, leading to a gradual shift in patient preferences toward more refined products.</p>

<p>Cannabinoid Oils (Dominant) vs. Edibles (Emerging)</p>

<p>Cannabinoid Oils have solidified their position as the dominant formulation segment due to their concentrated nature and ease of use. They offer precise dosing and fast-acting relief, which are critical for patients with <a href="https://www.marketresearchfuture.com/reports/chronic-granulomatous-disease-market-6447">chronic</a> conditions. On the other hand, Edibles are emerging rapidly, appealing particularly to those who prefer a more palatable option. The growth of this segment is fueled by innovation in flavor and product variety, making cannabis more accessible to non-traditional users. As regulations ease, both segments are likely to continue evolving, appealing to a broader market.</p>

By Distribution Channel: Dispensaries (Largest) vs. Online Stores (Fastest-Growing)

<p>In the Medical Marijuana Market, Dispensaries hold the largest market share among the distribution channels, serving as the primary source for consumers seeking medical cannabis products. Dispensaries provide a personalized shopping experience, allowing patients to obtain tailored advice from knowledgeable staff, thus enhancing customer satisfaction and fostering loyalty. Online Stores, while currently having a smaller share compared to Dispensaries, are rapidly gaining traction due to their convenience and accessibility, making it easier for patients to access medical marijuana from the comfort of their homes. Growth in the Medical Marijuana Market is increasingly driven by the shift towards online purchasing, particularly as consumers seek greater ease and efficiency in accessing their medical needs. Factors such as improved logistics, regulatory advances supporting online sales, and the rising acceptance of medical marijuana are providing significant tailwinds for Online Stores. This segment’s growth is expected to accelerate as more patients become familiar with the benefits of online consultations and deliveries, contributing to an evolving market landscape alongside traditional Dispensaries.</p>

<p>Dispensaries (Dominant) vs. Online Stores (Emerging)</p>

<p>Dispensaries play a dominant role in the Medical Marijuana Market, providing an essential touchpoint for consumers looking for medicinal cannabis. They typically offer a wide range of products, including various strains and forms, and are often staffed by licensed professionals who can guide patients in selecting the right options for their needs. Their physical presence allows for immediate access, which is a significant advantage for users who require immediate relief. In contrast, Online Stores are an emerging segment that is quickly adapting to changing consumer preferences. They appeal to tech-savvy patients who prefer the convenience of browsing and purchasing from home. This evolution in consumer behavior has prompted many traditional dispensaries to expand or enhance their online presence, indicating a trend towards an integrated model that combines both physical and digital retailing.</p>

By End Use: Medical Institutions (Largest) vs. Homecare Settings (Fastest-Growing)

<p>In the Medical Marijuana Market, the distribution of market share among the end-use segments reveals that Medical Institutions hold the largest share. This segment encompasses various healthcare facilities where cannabis is utilized for therapeutic purposes, significantly contributing to the overall market growth. On the other hand, Homecare Settings are rapidly gaining traction, indicating a shift in consumer preferences for at-home medical treatment options. As the demand for alternative therapies continues to rise, Homecare Settings are poised for substantial growth, driven by an increase in patient awareness and positive attitudes towards medical marijuana. Moreover, the COVID-19 pandemic has accelerated the trend of remote treatment solutions, enabling patients to access medical marijuana from the comfort of their homes. This emerging trend presents significant opportunities for market players to cater to the evolving needs of patients seeking safe and effective at-home solutions.</p>

<p>Medical Institutions: Dominant vs. Homecare Settings: Emerging</p>

<p>Medical Institutions represent the dominant segment in the Medical Marijuana Market, characterized by their long-standing history of utilizing cannabis for treatment and research. These institutions include hospitals, clinics, and specialized healthcare centers where medical professionals prescribe marijuana for a variety of conditions. Their established infrastructure, coupled with regulatory support, enables them to maintain a significant market presence. Conversely, Homecare Settings are emerging as a vital segment fueled by increasing consumer demand for home-based therapies. Patients are more inclined to manage their health conditions at home, using medical marijuana as an accessible alternative to traditional pharmaceuticals. The growth in this segment highlights changing healthcare dynamics and a shift towards personalized patient care, inviting new market entrants and innovation.</p>

Get more detailed insights about Medical Marijuana Market Global Research Report - Forecast till 2035

Regional Insights

The Global Medical Marijuana Market is projected to showcase significant growth across various regions, with North America holding a majority share of the market. Valued at 10.5 USD Billion in 2024 and expected to rise to 24.5 USD Billion by 2035, North America benefits from progressive legislation and increasing acceptance of medical marijuana for therapeutic uses. Europe follows, with a market valuation of 4.0 USD Billion in 2024, anticipated to grow to 10.0 USD Billion by 2035, driven by rising healthcare costs and demand for alternative medicine.

The APAC region, valued at 2.75 USD Billion in 2024 and projected to reach 5.5 USD Billion in 2035, reflects a growing recognition of the medical benefits of cannabis, albeit with varying legal landscapes. South America, while currently valued at 0.75 USD Billion in 2024, is expected to grow to 2.0 USD Billion by 2035, as more countries consider legalization for medical purposes.

Lastly, the Middle East and Africa (MEA) region starts with a market value of 0.34 USD Billion in 2024, likely increasing to 3.0 USD Billion by 2035 due to evolving policies and awareness.Each region plays a vital role in the overall market dynamics, contributing to the Global Medical Marijuana Market revenue and providing diverse growth opportunities.

Medical Marijuana Market Region   Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Global Medical Marijuana Market has been experiencing significant growth and transformation over the past few years due to changing regulations, increased acceptance of cannabis for medical use, and expanding therapeutic applications. As more countries legalize medical marijuana, the competitive landscape becomes increasingly dynamic, with numerous players vying for market share. Companies in this sector are focusing on innovative cultivation techniques, product development, and strategic partnerships to enhance their offerings and meet the growing demand from patients and healthcare providers.

Additionally, competition extends beyond product availability, encompassing branding, distribution channels, and consumer education, which ultimately plays a crucial role in shaping the market's trajectory. Given the multifaceted challenges and opportunities within this market, organizations must continuously adapt their strategies to maintain a competitive edge while ensuring compliance with evolving regulations.

Trulieve has established itself as a formidable player in the Global Medical Marijuana Market through a robust operational model and a strong geographic presence. The company leverages its extensive cultivation and production facilities to deliver a diverse range of high-quality cannabis products, including oils, concentrates, and flower. Trulieve's commitment to customer-centric service is evident in its patient education initiatives, which aim to enhance understanding and access to medical marijuana therapies. Furthermore, the company's strategic focus on expanding its footprint in key regions has augmented its presence in traditional and emerging markets.

Trulieve's competitive strengths lie in its established brand loyalty, sophisticated supply chain management, and a reputation for producing reliable, lab-tested products, which further bolster its standing in an increasingly crowded marketplace.

Aphria, operating on a global scale, is also a significant competitor in the Medical Marijuana Market, known for its extensive portfolio of products designed to meet diverse patient needs. The company specializes in a range of high-quality cannabis offerings, including oils, capsules, and other delivery methods, ensuring accessibility for various therapeutic applications. Aphria has strategically positioned itself within the market, not only through organic growth but also via mergers and acquisitions that have bolstered its market presence and expanded its product lineup. This proactive approach enables the company to scale operations efficiently while remaining agile in responding to market trends.

With strengths in research and development, customer service, and a strong ethos surrounding quality assurance, Aphria continues to innovate within the global landscape, ensuring it remains a key player in the evolving Medical Marijuana Market.

Key Companies in the Medical Marijuana Market market include

Industry Developments

The Global Medical Marijuana Market has seen significant developments recently, with various companies expanding their operations and product offerings. Trulieve announced the opening of additional retail locations to enhance patient access, while Aphria is focusing on boosting production capacity to meet increasing demand. HEXO Corp and Tilray announced their strategic collaboration to create innovative cannabinoid products, aimed at achieving a stronger market presence. Notably, in May 2023, Canopy Growth and Aurora Cannabis finalized a merger, reshaping the competitive landscape by creating a powerful entity capable of producing a wide range of medical marijuana products.

Meanwhile, Green Thumb Industries and Curaleaf have shown impressive growth in market valuation, positively influencing the overall investor sentiment in the market.

This growth is propelled by an increasing acceptance of medical marijuana globally, with regulations becoming more favorable in several jurisdictions. Furthermore, the Global Medical Marijuana Market is expected to expand significantly over the next few years, driven by a rising number of patients seeking alternative treatment options and ongoing advancements in product formulations. Recent regulatory changes in countries like Germany and Canada continue to facilitate the industry's expansion, creating a more robust global marketplace for medical cannabis.

Future Outlook

Medical Marijuana Market Future Outlook

<p>The Medical Marijuana Market is projected to grow at an 8.5% CAGR from 2024 to 2035, driven by increasing legalization, expanding patient demographics, and advancements in product formulations.</p>

New opportunities lie in:

  • <p>Development of telehealth platforms for remote consultations and prescriptions.</p><p>Investment in automated cultivation technologies to enhance yield efficiency.</p><p>Expansion of educational programs for healthcare professionals on medical marijuana benefits.</p>

<p>By 2035, the Medical Marijuana Market is expected to be robust, driven by innovation and increased acceptance.</p>

Market Segmentation

Medical Marijuana Market End Use Outlook

  • Medical Institutions
  • Homecare Settings
  • Research Institutions

Medical Marijuana Market Application Outlook

  • Chronic Pain
  • Neurological Disorders
  • Cancer
  • Mental Health Disorders
  • Appetite Loss

Medical Marijuana Market Formulation Outlook

  • Cannabinoid Oils
  • Dried Flowers
  • Edibles
  • Tinctures
  • Topicals

Medical Marijuana Market Distribution Channel Outlook

  • Pharmacies
  • Online Stores
  • Dispensaries
  • Hospitals

Report Scope

MARKET SIZE 202418.34(USD Billion)
MARKET SIZE 202519.9(USD Billion)
MARKET SIZE 203544.99(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)8.5% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesExpansion of telehealth services enhances patient access to Medical Marijuana prescriptions.
Key Market DynamicsEvolving regulatory frameworks and consumer preferences drive innovation and competition in the Medical Marijuana Market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Medical Marijuana Market?

The Medical Marijuana Market was valued at 18.34 USD Billion in 2024.

What is the projected market size for the Medical Marijuana Market by 2035?

The market is projected to reach 44.99 USD Billion by 2035.

What is the expected CAGR for the Medical Marijuana Market during the forecast period?

The expected CAGR for the Medical Marijuana Market from 2025 to 2035 is 8.5%.

Which companies are considered key players in the Medical Marijuana Market?

Key players include Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, Aphria, Canopy Growth, Aurora Cannabis, MedMen, and Harvest Health &amp; Recreation.

What are the primary applications driving the Medical Marijuana Market?

Chronic pain, neurological disorders, cancer, mental health disorders, and appetite loss are the primary applications.

How much revenue is generated from the Chronic Pain segment in the Medical Marijuana Market?

The Chronic Pain segment generated 6.0 USD Billion in 2024 and is projected to reach 14.5 USD Billion by 2035.

What formulation types are prevalent in the Medical Marijuana Market?

Cannabinoid oils, dried flowers, edibles, tinctures, and topicals are prevalent formulation types.

What is the revenue projection for the Dried Flowers segment by 2035?

The Dried Flowers segment is projected to generate 12.0 USD Billion by 2035.

Which distribution channels are most significant in the Medical Marijuana Market?

Dispensaries, pharmacies, online stores, and hospitals are significant distribution channels.

What is the expected revenue from Medical Institutions by 2035?

Revenue from Medical Institutions is expected to reach 15.0 USD Billion by 2035.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Application (USD Billion)
      1. Chronic Pain
      2. Neurological Disorders
      3. Cancer
      4. Mental Health Disorders
      5. Appetite Loss
    2. Healthcare, BY Formulation (USD Billion)
      1. Cannabinoid Oils
      2. Dried Flowers
      3. Edibles
      4. Tinctures
      5. Topicals
    3. Healthcare, BY Distribution Channel (USD Billion)
      1. Pharmacies
      2. Online Stores
      3. Dispensaries
      4. Hospitals
    4. Healthcare, BY End Use (USD Billion)
      1. Medical Institutions
      2. Homecare Settings
      3. Research Institutions
    5. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Curaleaf (US)
      2. Trulieve (US)
      3. Green Thumb Industries (US)
      4. Cresco Labs (US)
      5. Aphria (CA)
      6. Canopy Growth (CA)
      7. Aurora Cannabis (CA)
      8. MedMen (US)
      9. Harvest Health & Recreation (US)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. NORTH AMERICA MARKET ANALYSIS
    6. US MARKET ANALYSIS BY APPLICATION
    7. US MARKET ANALYSIS BY FORMULATION
    8. US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    9. US MARKET ANALYSIS BY END USE
    10. CANADA MARKET ANALYSIS BY APPLICATION
    11. CANADA MARKET ANALYSIS BY FORMULATION
    12. CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    13. CANADA MARKET ANALYSIS BY END USE
    14. EUROPE MARKET ANALYSIS
    15. GERMANY MARKET ANALYSIS BY APPLICATION
    16. GERMANY MARKET ANALYSIS BY FORMULATION
    17. GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    18. GERMANY MARKET ANALYSIS BY END USE
    19. UK MARKET ANALYSIS BY APPLICATION
    20. UK MARKET ANALYSIS BY FORMULATION
    21. UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    22. UK MARKET ANALYSIS BY END USE
    23. FRANCE MARKET ANALYSIS BY APPLICATION
    24. FRANCE MARKET ANALYSIS BY FORMULATION
    25. FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    26. FRANCE MARKET ANALYSIS BY END USE
    27. RUSSIA MARKET ANALYSIS BY APPLICATION
    28. RUSSIA MARKET ANALYSIS BY FORMULATION
    29. RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    30. RUSSIA MARKET ANALYSIS BY END USE
    31. ITALY MARKET ANALYSIS BY APPLICATION
    32. ITALY MARKET ANALYSIS BY FORMULATION
    33. ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    34. ITALY MARKET ANALYSIS BY END USE
    35. SPAIN MARKET ANALYSIS BY APPLICATION
    36. SPAIN MARKET ANALYSIS BY FORMULATION
    37. SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    38. SPAIN MARKET ANALYSIS BY END USE
    39. REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    40. REST OF EUROPE MARKET ANALYSIS BY FORMULATION
    41. REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    42. REST OF EUROPE MARKET ANALYSIS BY END USE
    43. APAC MARKET ANALYSIS
    44. CHINA MARKET ANALYSIS BY APPLICATION
    45. CHINA MARKET ANALYSIS BY FORMULATION
    46. CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    47. CHINA MARKET ANALYSIS BY END USE
    48. INDIA MARKET ANALYSIS BY APPLICATION
    49. INDIA MARKET ANALYSIS BY FORMULATION
    50. INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    51. INDIA MARKET ANALYSIS BY END USE
    52. JAPAN MARKET ANALYSIS BY APPLICATION
    53. JAPAN MARKET ANALYSIS BY FORMULATION
    54. JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    55. JAPAN MARKET ANALYSIS BY END USE
    56. SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    57. SOUTH KOREA MARKET ANALYSIS BY FORMULATION
    58. SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    59. SOUTH KOREA MARKET ANALYSIS BY END USE
    60. MALAYSIA MARKET ANALYSIS BY APPLICATION
    61. MALAYSIA MARKET ANALYSIS BY FORMULATION
    62. MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    63. MALAYSIA MARKET ANALYSIS BY END USE
    64. THAILAND MARKET ANALYSIS BY APPLICATION
    65. THAILAND MARKET ANALYSIS BY FORMULATION
    66. THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    67. THAILAND MARKET ANALYSIS BY END USE
    68. INDONESIA MARKET ANALYSIS BY APPLICATION
    69. INDONESIA MARKET ANALYSIS BY FORMULATION
    70. INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    71. INDONESIA MARKET ANALYSIS BY END USE
    72. REST OF APAC MARKET ANALYSIS BY APPLICATION
    73. REST OF APAC MARKET ANALYSIS BY FORMULATION
    74. REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    75. REST OF APAC MARKET ANALYSIS BY END USE
    76. SOUTH AMERICA MARKET ANALYSIS
    77. BRAZIL MARKET ANALYSIS BY APPLICATION
    78. BRAZIL MARKET ANALYSIS BY FORMULATION
    79. BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    80. BRAZIL MARKET ANALYSIS BY END USE
    81. MEXICO MARKET ANALYSIS BY APPLICATION
    82. MEXICO MARKET ANALYSIS BY FORMULATION
    83. MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    84. MEXICO MARKET ANALYSIS BY END USE
    85. ARGENTINA MARKET ANALYSIS BY APPLICATION
    86. ARGENTINA MARKET ANALYSIS BY FORMULATION
    87. ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    88. ARGENTINA MARKET ANALYSIS BY END USE
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    90. REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION
    91. REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    92. REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    93. MEA MARKET ANALYSIS
    94. GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    95. GCC COUNTRIES MARKET ANALYSIS BY FORMULATION
    96. GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    97. GCC COUNTRIES MARKET ANALYSIS BY END USE
    98. SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    99. SOUTH AFRICA MARKET ANALYSIS BY FORMULATION
    100. SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    101. SOUTH AFRICA MARKET ANALYSIS BY END USE
    102. REST OF MEA MARKET ANALYSIS BY APPLICATION
    103. REST OF MEA MARKET ANALYSIS BY FORMULATION
    104. REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    105. REST OF MEA MARKET ANALYSIS BY END USE
    106. KEY BUYING CRITERIA OF HEALTHCARE
    107. RESEARCH PROCESS OF MRFR
    108. DRO ANALYSIS OF HEALTHCARE
    109. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    110. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    111. SUPPLY / VALUE CHAIN: HEALTHCARE
    112. HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    113. HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    114. HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
    115. HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Billion)
    116. HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    117. HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    118. HEALTHCARE, BY END USE, 2024 (% SHARE)
    119. HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    120. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    121. LIST OF ASSUMPTIONS
    122. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    123. US MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    124. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    125. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    126. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    127. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    128. France MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    129. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    130. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    131. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    132. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    133. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    134. China MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    135. India MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    136. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    137. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    138. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    139. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    140. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    141. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    142. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    143. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    144. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    145. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    146. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    147. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    148. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    149. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    150. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY APPLICATION, 2025-2035 (USD Billion)
      2. BY FORMULATION, 2025-2035 (USD Billion)
      3. BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    151. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    152. ACQUISITION/PARTNERSHIP

Medical Marijuana Market Segmentation

Medical Marijuana Market By Application (USD Billion, 2019-2035)

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

Medical Marijuana Market By Formulation (USD Billion, 2019-2035)

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

Medical Marijuana Market By Distribution Channel (USD Billion, 2019-2035)

Pharmacies

Online Stores

Dispensaries

Hospitals

Medical Marijuana Market By End Use (USD Billion, 2019-2035)

Medical Institutions

Homecare Settings

Research Institutions

Medical Marijuana Market By Regional (USD Billion, 2019-2035)

North America

Europe

South America

Asia Pacific

Middle East and Africa

Medical Marijuana Market Regional Outlook (USD Billion, 2019-2035)

North America Outlook (USD Billion, 2019-2035)

North America Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

North America Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

North America Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

North America Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

North America Medical Marijuana Market by Regional Type

US

Canada

US Outlook (USD Billion, 2019-2035)

US Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

US Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

US Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

US Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

CANADA Outlook (USD Billion, 2019-2035)

CANADA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

CANADA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

CANADA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

CANADA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

Europe Outlook (USD Billion, 2019-2035)

Europe Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

Europe Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

Europe Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

Europe Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

Europe Medical Marijuana Market by Regional Type

Germany

UK

France

Russia

Italy

Spain

Rest of Europe

GERMANY Outlook (USD Billion, 2019-2035)

GERMANY Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

GERMANY Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

GERMANY Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

GERMANY Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

UK Outlook (USD Billion, 2019-2035)

UK Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

UK Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

UK Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

UK Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

FRANCE Outlook (USD Billion, 2019-2035)

FRANCE Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

FRANCE Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

FRANCE Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

FRANCE Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

RUSSIA Outlook (USD Billion, 2019-2035)

RUSSIA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

RUSSIA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

RUSSIA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

RUSSIA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

ITALY Outlook (USD Billion, 2019-2035)

ITALY Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

ITALY Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

ITALY Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

ITALY Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

SPAIN Outlook (USD Billion, 2019-2035)

SPAIN Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

SPAIN Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

SPAIN Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

SPAIN Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

REST OF EUROPE Outlook (USD Billion, 2019-2035)

REST OF EUROPE Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

REST OF EUROPE Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

REST OF EUROPE Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

REST OF EUROPE Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

APAC Outlook (USD Billion, 2019-2035)

APAC Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

APAC Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

APAC Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

APAC Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

APAC Medical Marijuana Market by Regional Type

China

India

Japan

South Korea

Malaysia

Thailand

Indonesia

Rest of APAC

CHINA Outlook (USD Billion, 2019-2035)

CHINA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

CHINA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

CHINA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

CHINA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

INDIA Outlook (USD Billion, 2019-2035)

INDIA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

INDIA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

INDIA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

INDIA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

JAPAN Outlook (USD Billion, 2019-2035)

JAPAN Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

JAPAN Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

JAPAN Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

JAPAN Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

SOUTH KOREA Outlook (USD Billion, 2019-2035)

SOUTH KOREA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

SOUTH KOREA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

SOUTH KOREA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

SOUTH KOREA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

MALAYSIA Outlook (USD Billion, 2019-2035)

MALAYSIA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

MALAYSIA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

MALAYSIA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

MALAYSIA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

THAILAND Outlook (USD Billion, 2019-2035)

THAILAND Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

THAILAND Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

THAILAND Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

THAILAND Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

INDONESIA Outlook (USD Billion, 2019-2035)

INDONESIA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

INDONESIA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

INDONESIA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

INDONESIA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

REST OF APAC Outlook (USD Billion, 2019-2035)

REST OF APAC Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

REST OF APAC Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

REST OF APAC Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

REST OF APAC Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

South America Outlook (USD Billion, 2019-2035)

South America Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

South America Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

South America Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

South America Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

South America Medical Marijuana Market by Regional Type

Brazil

Mexico

Argentina

Rest of South America

BRAZIL Outlook (USD Billion, 2019-2035)

BRAZIL Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

BRAZIL Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

BRAZIL Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

BRAZIL Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

MEXICO Outlook (USD Billion, 2019-2035)

MEXICO Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

MEXICO Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

MEXICO Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

MEXICO Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

ARGENTINA Outlook (USD Billion, 2019-2035)

ARGENTINA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

ARGENTINA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

ARGENTINA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

ARGENTINA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

REST OF SOUTH AMERICA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

REST OF SOUTH AMERICA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

REST OF SOUTH AMERICA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

REST OF SOUTH AMERICA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

MEA Outlook (USD Billion, 2019-2035)

MEA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

MEA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

MEA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

MEA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

MEA Medical Marijuana Market by Regional Type

GCC Countries

South Africa

Rest of MEA

GCC COUNTRIES Outlook (USD Billion, 2019-2035)

GCC COUNTRIES Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

GCC COUNTRIES Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

GCC COUNTRIES Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

GCC COUNTRIES Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

SOUTH AFRICA Outlook (USD Billion, 2019-2035)

SOUTH AFRICA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

SOUTH AFRICA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

SOUTH AFRICA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

SOUTH AFRICA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

REST OF MEA Outlook (USD Billion, 2019-2035)

REST OF MEA Medical Marijuana Market by Application Type

Chronic Pain

Neurological Disorders

Cancer

Mental Health Disorders

Appetite Loss

REST OF MEA Medical Marijuana Market by Formulation Type

Cannabinoid Oils

Dried Flowers

Edibles

Tinctures

Topicals

REST OF MEA Medical Marijuana Market by Distribution Channel Type

Pharmacies

Online Stores

Dispensaries

Hospitals

REST OF MEA Medical Marijuana Market by End Use Type

Medical Institutions

Homecare Settings

Research Institutions

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions